共 251 条
[1]
Jönsson L(2006)Determinants of costs of care for patients with Alzheimer’s disease Int J Geriatr Psychiatry 21 449-459
[2]
Eriksdotter Jönhagen M(2017)Disease progression in mild dementia due to Alzheimer disease in an 18-month observational study (GERAS): the impact on costs and caregiver outcomes Dement Geriatr Cogn Disord Extra 7 87-100
[3]
Kilander L(1995)Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer’s dementia Pharmacopsychiatry 28 113-124
[4]
Jones RW(1995)MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis Eur J Pharmacol 293 267-270
[5]
Lebrec J(2015)EFNS-ENS/EAN guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease Eur J Neurol 22 889-898
[6]
Kahle-Wrobleski K(2017)Trends in the prescription and long-term utilization of antidementia drugs among patients with Alzheimer's disease in Spain: a cohort study using the registry of dementias of Girona Drugs Aging 34 303-310
[7]
Müller WE(2017)prescription patterns of medications for Alzheimer’s disease in Japan from 2010 to 2015: a descriptive pharmacy claims database study Neurol Ther 6 25-37
[8]
Mutschler E(2016)Treatment patterns with antidementia drugs in the united sates: Meidcare cohort study J Am Geriatr Soc 64 1540-1548
[9]
Riederer P(2014)Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study Int Clin Psychopharmacol 29 216-223
[10]
Wenk GL(2006)Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease N Engl J Med 355 1525-1538